• About us
    • About Lindahl
    • How we work
    • Said about Lindahl
    • Press
    • Find us
    • Privacy
  • Areas
    • Commercial dispute resolution
    • IT/Tech
    • Intellectual property
    • Life Sciences
    • M&A
    • All areas
  • Our people
    • Stockholm
    • Göteborg
    • Malmö
    • Uppsala
    • Helsingborg
    • Örebro
  • Latest news
    • Cases and transactions
    • News
    • Events
    • Knowledge
    • Portraits
  • Offices
    • Stockholm
    • Göteborg
    • Malmö
    • Uppsala
    • Örebro
    • Helsingborg

Lindahl has advised Biosergen AB in connection with the company’s issue of units and listing on Nasdaq First North Growth Market.

  • Home
  • Latest news
  • Cases and transactions
  • 2021
  • Lindahl has advised Biosergen AB in connection with the company’s issue of units and listing on Nasdaq First North Growth Market.

Biosergen has carried out an issue of 5,000,000 units to the public in Sweden, Denmark and Norway. Through the issue, the company receives SEK 50 million before the deduction of issue costs. The trading on Nasdaq First North Growth Market is expected to begin on June 24, 2021.

Biosergen focuses exclusively on the development of the antifungal product BSG005. BSG005 is an innovative new antifungal for the treatment of life threatening invasive fungal disease.

Lindahl’s team consisted of Monica Lagercrantz (partner), Jenny Strandberg, Gustav Ahlgren and Ola Svanberg.

Contact

  • Monica Lagercrantz

    Stockholm

    monica.lagercrantz@lindahl.se +46 761 269 109
  • Gustav Ahlgren

    Stockholm

    gustav.ahlgren@lindahl.se +46 734 158 215
  • Ola Svanberg

    Stockholm

    ola.svanberg@lindahl.se +46 761 269 115
Pages
  • Start
  • About us
  • Areas
  • Our people
  • Latest news
  • Privacy
Our offices
  • Stockholm reception.stockholm@lindahl.se +46 8 527 70 800
  • Göteborg reception.goteborg@lindahl.se +46 31 799 10 00
  • Malmö reception.malmo@lindahl.se +46 40 664 66 50
  • Uppsala reception.uppsala@lindahl.se +46 18 16 18 50
  • Örebro reception.orebro@lindahl.se +46 19 20 89 00
  • Helsingborg reception.helsingborg@lindahl.se +46 42 17 53 00
Social media
  • Connect with us on social networks: Instagram, Linkedin, Youtube, Facebook,

Disclaimer

The material and information on this site is intended for general informational purposes only and does not constitute legal advice on any specific matter. Please note that all images on Lindahl's website, www.lindahl.se, are subject to intellectual property protection and downloading, publication, copying and/or other use of the images requires the written consent of the rights holder. You'll find Advokatfirman Lindahl KB's general terms and conditions here.

Some cookies are essential, others help us improve your experience by providing insights into how the site is used. For more information, please visit our Cookie Policy.

Essential Cookies

These cookies are necessary for the functionality of the site and cannot be disabled.

Analytics Cookies>

We use Analytics cookies to collect information that gives us insight into how our website is being used. We anonymize IP addresses in Google Analytics. By clicking on Decline we won't save theese cookies.

Decline
We use cookies to get insights on how our site is used and give our visitors the best possible experience